0001723443-26-000006.txt : 20261014 0001723443-26-000006.hdr.sgml : 20261014 20261014122834 ACCESSION NUMBER: 0001723443-26-000006 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261014 DATE AS OF CHANGE: 20261014 EFFECTIVENESS DATE: 20261014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InSitu Biologics, Inc. CENTRAL INDEX KEY: 0001723443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 823415514 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-593640 FILM NUMBER: 261459127 BUSINESS ADDRESS: STREET 1: 3510 HOPKINS PLACE N. STREET 2: BUILDING 4 CITY: OAKDALE STATE: MN ZIP: 55128 BUSINESS PHONE: 651-337-4799 MAIL ADDRESS: STREET 1: 3510 HOPKINS PLACE N. STREET 2: BUILDING 4 CITY: OAKDALE STATE: MN ZIP: 55128 FORMER COMPANY: FORMER CONFORMED NAME: InSitu Biologics, Inc DATE OF NAME CHANGE: 20171121 D/A 1 primary_doc.xml X0708 D/A LIVE 0001723443 InSitu Biologics, Inc. 3510 HOPKINS PLACE N. BUILDING 4 OAKDALE MN MINNESOTA 55128 651-337-4799 DELAWARE InSitu Biologics, Inc Corporation true Daniel Halpern 3510 Hopkins Place N. Building 4 Oakdale MN MINNESOTA 55128 Executive Officer Director Bill Taylor 3510 Hopkins Place N. Building 4 Oakdale MN MINNESOTA 55128 Executive Officer Sandi Klemann 3510 Hopkins Place N. Building 4 Oakdale MN MINNESOTA 55128 Executive Officer Robert Wilson 3510 Hopkins Place N. Building 4 Oakdale MN MINNESOTA 55128 Director Greg Van Guilder 3510 Hopkins Place N. Building 4 Oakdale MN MINNESOTA 55128 Director Ivan Shaw 3510 Hopkins Place N. Building 4 Oakdale MN MINNESOTA 55128 Director Biotechnology Decline to Disclose 06b true 0001723443-26-000005 2026-08-04 false true true true Convertible Promissory Note false 2500000 3375000 1250000 2125000 false 1 0 0 0 Excludes ordinary course compensation paid to officers. false InSitu Biologics, Inc. /s/ Daniel Halpern Daniel Halpern Chief Executive Officer 2026-10-13